Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Electronic Records Communicate Quickly, Satisfy Patients
LifeBridge Health in Baltimore, Maryland is one of the few heath care systems with computerized records that can now be accessed across our whole system, which includes two acute hospitals, one sub-acute hospital and two nursing homes.
generic viagra online
Rise In Homicide By Mentally Ill In England And Wales
The number of people killed by individuals suffering from mental illness in England and Wales increased between 1997 and 2005, figures show. The rise occurred in people who were not under mental health care and was not found in mental health patients.
News of the day
Blogs Comment On Ryan-DeLauro Bill, Sex Education Funding, State Reproductive Health Legislation
The following summarizes selected women"s health-related blog entries.~ "A Taxing Problem," Jessica Arons, Huffington Post blogs: The five Democrats who last week sent a letter to House Speaker Nancy Pelosi (D-Calif.) "suggesting a "common ground" solution to the abortion "roadblock" in health care reform" should be "applauded" for keeping the debate"s focus on covering the uninsured and "for being unwilling to sacrifice health care reform on the altar of abortion politics," writes Jessica Arons, director of the Women"s Health & Rights Program at the Center for American Progress. Arons adds that while the proposal, led by antiabortion-rights Rep. Tim Ryan (D-Ohio), "is in welcome contrast to the stonewalling and ultimatums coming from Rep. Bart Stupak (D-Mich.) and his allies," it is "based on a misguided and attenuated definition of government spending, and it conflicts with what Americans want and expect from health care reform." She continues that the "suggestion that a health plan might offer abortion coverage, and it might be used by someone, who might have paid a lower premium than someone else, because the government might have helped pay their premium is a horrible reason for Congress to carve out an explicit exception to a bill that is otherwise entirely silent on coverage options." Taxpayers "do not have the right to specify how their tax money should be spent," she writes, adding, "I understand why people would want to withhold their taxes from purposes they oppose, but our system does not -- nor should it -- work that way" (Arons, Huffington Post blogs, 7/30).~ "The Breakup of the Pro-Life Movement," Cristina Page, Birth Control Watch: Rep. Ryan is "in many ways a typical pro-life American" who opposes abortion rights and, "like most pro-life Americans, ... supports every effort to prevent the need for it," including contraception, Page writes. However, because of his support for contraception and sponsorship of the "Preventing Unintended Pregnancies, Reducing the Need for Abortion and Supporting Parents Act," Ryan was "banished" from the board of Democrats for Life of America, Page writes, adding that antiabortion-rights publications have "taken to qualifying his pro-life status as "allegedly" pro-life or referring to him as someone "who claims to be" pro-life." The bill, also known as the Ryan-DeLauro bill, would increase funding for contraception, and support comprehensive sex education and services for women who choose to carry unintended pregnancies to term, Page writes. She notes that the bill is supported by "many prominent pro-life individuals" and groups that support abortion rights, though "[n]ot one leading pro-life group signed onto the bill." Page writes, "Pro-life Americans favor expanding access to contraception because of the undeniable pro-life results," adding, "Unintended pregnancy is the root cause of abortion. We know when used properly, contraception works." It is "time for the disagreement over contraception to be addressed by the pro-life community at large," she writes, adding, "We will have no chance of making a real impact on unintended pregnancy and abortion rates without dramatic, informed strategies on prevention" (Page, Birth Control Watch, 7/28).~ "Senate Subcommittee: Ab-Only Out, Syringe Ban Still In; Advocates Hope for Further Changes in Conference Committee," Jodi Jacobson, RH Reality Check: The spending bill approved yesterday by the Senate Appropriations Committee "zeroes out funding" for the Community-Based Abstinence Education program, which has "for years [been] the main of support for now-discredited abstinence-only programs," Jacobson writes. The "elimination of these funds parallels similar action in the House, ... so unless amendments are proposed, accepted and passed during either the full committee vote or on the Senate floor, this bill spells "the end of abstinence-only programs as we know them," said one advocate, "at least for this year,"" Jacobson writes. The Senate version of the bill allocate
Public Health

Elsevier's PharmaPendium Introduces The FDA Classic Collection

PharmaPendium, Elsevier"s online re for authoritative preclinical, clinical and post-marketing drug information, has significantly expanded its coverage of US Food and Drug Administration (FDA) approval documents with the launch of the FDA Classic Collection. This collection contains all available historical FDA approval documents up to and including those issued in 1991 - all indexed and made searchable for the first time in history. With the addition of the FDA Classic Collection, PharmaPendium has become the only integrated, searchable of all FDA drug approval documents. The combination of PharmaPendium"s current FDA database and the FDA Classic Collection creates an entire searchable library of documents written by the FDA on the approval of drugs and their pharmacokinetics, efficacy and safety. The FDA Classic Collection may be searched simultaneously with the current file (1992-present) or as a discrete database. "For success within the pharmaceutical industry it"s critical to gain and maintain a strong competitive advantage and avoid lost opportunities, lost sales, wasted trials and regulatory recycling. The addition of the FDA Classic Collection to PharmaPendium gives pharmaceutical companies the advantage of being able to gain a unique perspective into the past, enabling them to benefit from information that has not been available for close to 50 years. Users will be able to apply modern analyses tools to these data for the first time, generating new insights. They will no longer encounter information dead ends because every citation to a previous FDA document is now traceable, searchable and viewable," commented Philip MacLaughlin, Senior Product Manager at Elsevier. Most of the documents in PharmaPendium"s FDA Classic Collection were previously available only through direct requests to the FDA/Center for Drug Evaluation and Research Freedom of Information Office and had to be pulled from microfiche. "Now users can locate and search these historic documents in just seconds to uncover regulatory precedents, learn from historic mistakes and successes and apply these lessons to current projects in the drug pipeline," continued MacLaughlin. The FDA Classic Collection may be added to new or existing PharmaPendium licenses for an additional fee. PharmaPendium is a trademark of Elsevier Inc. Tom Reller Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009